Anaphylaxis: Recognizing Risk and Targeting Treatment

Research output: Contribution to journalEditorial

LanguageEnglish (US)
Pages1224-1226
Number of pages3
JournalJournal of Allergy and Clinical Immunology: In Practice
Volume5
Issue number5
DOIs
StatePublished - Sep 1 2017

Fingerprint

Anaphylaxis

ASJC Scopus subject areas

  • Immunology and Allergy

Cite this

Anaphylaxis : Recognizing Risk and Targeting Treatment. / Golden, David B.K.

In: Journal of Allergy and Clinical Immunology: In Practice, Vol. 5, No. 5, 01.09.2017, p. 1224-1226.

Research output: Contribution to journalEditorial

@article{6deaab7a5bb445ea93936fb916e60aee,
title = "Anaphylaxis: Recognizing Risk and Targeting Treatment",
author = "Golden, {David B.K.}",
year = "2017",
month = "9",
day = "1",
doi = "10.1016/j.jaip.2017.06.028",
language = "English (US)",
volume = "5",
pages = "1224--1226",
journal = "Journal of Allergy and Clinical Immunology: In Practice",
issn = "2213-2198",
publisher = "Elsevier",
number = "5",

}

TY - JOUR

T1 - Anaphylaxis

T2 - Journal of Allergy and Clinical Immunology: In Practice

AU - Golden,David B.K.

PY - 2017/9/1

Y1 - 2017/9/1

UR - http://www.scopus.com/inward/record.url?scp=85029000870&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85029000870&partnerID=8YFLogxK

U2 - 10.1016/j.jaip.2017.06.028

DO - 10.1016/j.jaip.2017.06.028

M3 - Editorial

VL - 5

SP - 1224

EP - 1226

JO - Journal of Allergy and Clinical Immunology: In Practice

JF - Journal of Allergy and Clinical Immunology: In Practice

SN - 2213-2198

IS - 5

ER -